Compounds > 1-methyl-3-isobutylxanthine

1-methyl-3-isobutylxanthine and fpl 55712

1-methyl-3-isobutylxanthine has been researched along with fpl 55712 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coutts, S; Gordon, R; Jolly, S; Khandwala, A; Sonnino, P; Van Inwegen, RG1
Cieslinksi, LB; Foley, JJ; Kopia, GA; Sarau, HM; Torphy, TJ; Valocik, RE; Wasserman, MA1

Other Studies

2 other study(ies) available for 1-methyl-3-isobutylxanthine and fpl 55712

ArticleYear
REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Chromones; Coronary Circulation; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Hydroxyquinolines; Kinetics; Lung; Male; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Myocardial Contraction; Quinolines; Regional Blood Flow; SRS-A

1987
Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Chromones; Coronary Circulation; Dicarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Lipoxygenase Inhibitors; SRS-A; Sulfonamides; Vasoconstriction

1987